Free Newsletter
Vaccine makers to produce record amount of flu jab
The five key vaccine makers say they plan to produce a record 143 million doses of flu vaccine for the U.S. market next season, which should be enough to satisfy demand. Manufacturers delivered 140 million doses for the last flu season, most of which were useless against the strains that were actually in circulation. Each year some 200,000 people in the U.S. are hospitalized for the flu, and 36,000 people die from it.
- read the report from Newsday
Related Articles:
Flu jab missing the mark in seasonal campaign
Vaccines not useful for seasonal flu
Universal flu vaccine shows early promise
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: